|
市場調査レポート
商品コード
1578325
ADME毒性試験の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測Global ADME Toxicology Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
||||||
カスタマイズ可能
|
|||||||
| ADME毒性試験の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年～2032年の予測 |
|
出版日: 2024年09月01日
発行: Value Market Research
ページ情報: 英文 332 Pages
納期: 即日から翌営業日
|
- 全表示
- 概要
- 図表
- 目次
ADME毒性試験市場の世界需要は、2023年の102億7,000万米ドルから2032年にはほぼ257億9,000万米ドルの市場規模に達すると推定され、調査期間2024-2032年のCAGRは10.77%です。
ADMEとは薬理学の略語で、化学物質や薬物の吸収、分布、代謝、排泄を意味し、人体への影響を調べます。これら4つの検査方法により、特定の薬物や化学物質が人体組織に与える影響を定義します。ADME毒性試験は、新薬が市場に導入される前の重要な手順です。このような毒物学的試験は、体組織への薬物曝露の薬物レベルと動態に影響を与え、その結果、製薬会社の創薬時間や試験の複雑さを軽減し、医薬品開発のコストを最小限に抑えるためのパフォーマンスを促進します。
市場力学
医薬品開発プロセスにおけるさまざまな検査に関連するコストの減少を理由に、世界中のさまざまな製薬会社やバイオテクノロジー企業からの需要が高まっていることが、市場の成長を促しています。さらに、新薬の商業化にかかる時間の短縮と、薬物検査の失敗件数の減少が、市場の成長をさらに後押ししています。しかし、このようなシステムを操作する熟練した専門家の不足とともに、高い設置費用とメンテナンス費用が市場成長を抑制すると予想されます。
調査レポートは、ポーターのファイブフォースモデル、市場の魅力分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールはADME毒性試験の世界市場における各セグメントを包括的に評価することもできます。ADME毒性試験産業の成長と動向は、この研究に全体的なアプローチを提供します。
カスタム要件がある場合は、お問い合わせください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。
目次
第1章 序文
第2章 エグゼクティブサマリー
- 市場のハイライト
- 世界市場スナップショット
第3章 ADME毒性試験-産業分析
- イントロダクション：市場力学
- 市場促進要因
- 市場抑制要因
- 市場機会
- 業界動向
- ポーターのファイブフォース分析
- 市場の魅力分析
第4章 バリューチェーン分析
- バリューチェーン分析
- 原材料分析
- 原材料リスト
- 原材料メーカーリスト
- 主要原材料の価格動向
- 潜在的バイヤーリスト
- マーケティングチャネル
- ダイレクトマーケティング
- インダイレクトマーケティング
- マーケティングチャネル発展動向
第5章 ADME毒性試験の世界市場分析：技術別
- 概要
- 実績および予測データ分析
- 細胞培養
- ハイスループット
- 分子イメージング
- オミックス技術
第6章 ADME毒性試験の世界市場分析：用途別
- 概要
- 実績および予測データ分析
- 全身毒性
- 腎毒性
- 肝毒性
- 神経毒性
- その他の毒性
第7章 ADME毒性試験の世界市場分析：手法別
- 概要
- 実績および予測データ分析
- 細胞アッセイ
- 生化学アッセイ
- インシリカ
- 生体外
第8章 ADME毒性試験の世界市場分析：地域別
- 地域別展望
- イントロダクション
- 北米売上分析
- 概要、実績と予測
- 北米セグメント別
- 北米国別
- 米国
- カナダ
- メキシコ
- 欧州売上分析
- 概要、実績と予測
- 欧州セグメント別
- 欧州国別
- 英国
- フランス
- ドイツ
- イタリア
- ロシア
- その他欧州
- アジア太平洋地域売上分析
- 概要、実績と予測
- アジア太平洋地域セグメント別
- アジア太平洋地域国別
- 中国
- インド
- 日本
- 韓国
- オーストラリア
- 東南アジア
- その他アジア太平洋地域
- ラテンアメリカ売上分析
- 概要、実績と予測
- ラテンアメリカセグメント別
- ラテンアメリカ国別
- ブラジル
- アルゼンチン
- ペルー
- チリ
- その他ラテンアメリカ
- 中東・アフリカ売上分析
- 概要、実績と予測
- 中東・アフリカセグメント別
- 中東・アフリカ国別
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東とアフリカ
第9章 ADME毒性試験企業の競合情勢
- ADME毒性試験市場の競合
- 提携/協力/合意
- 合併・買収
- 新製品上市
- その他の開発
第10章 企業プロファイル
- 上位企業の市場シェア分析
- 市場集中度
- Thermo Fisher Scientific Inc.
- Promega Corp.
- Agilent Technologies Inc.
- Curia Global Inc.
- Dassault SysteMes
- Beckman Coulter Inc.
- Danaher
- Catalent Inc.
- Charles River Laboratories
- Labcorp Drug Development
- Eurofins Scientific
- GE HealthCare
- Miltenyi Biotec
- IQVIA Inc
LIST OF TABLES
- Market Snapshot
- Drivers: Impact Analysis
- Restraints: Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- Analysis By Technology (USD MN)
- Cell Culture Market Sales By Geography (USD MN)
- High Throughput Market Sales By Geography (USD MN)
- Molecular Imaging Market Sales By Geography (USD MN)
- OMICS Technology Market Sales By Geography (USD MN)
- Analysis By Application (USD MN)
- Systemic Toxicity Market Sales By Geography (USD MN)
- Renal Toxicity Market Sales By Geography (USD MN)
- Hepatotoxicity Market Sales By Geography (USD MN)
- Neurotoxicity Market Sales By Geography (USD MN)
- Other Toxicities Market Sales By Geography (USD MN)
- Analysis By Method (USD MN)
- Cellular Assay Market Sales By Geography (USD MN)
- Biochemical Assay Market Sales By Geography (USD MN)
- In-Silica Market Sales By Geography (USD MN)
- Ex-vivo Market Sales By Geography (USD MN)
- Global ADME Toxicology Testing Market Sales By Geography (USD MN)
- North America Market Analysis (USD MN)
- United States Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate By Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- South East Asia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisition
LIST OF FIGURES
- Research Scope of ADME Toxicology Testing Report
- Market Research Process
- Market Research Methodology
- Global ADME Toxicology Testing Market Size, By Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis By Technology
- Market Attractiveness Analysis By Application
- Market Attractiveness Analysis By Method
- Market Attractiveness Analysis By Region
- Value Chain Analysis
- Global Market Analysis By Technology (USD MN)
- Cell Culture Market Sales By Geography (USD MN)
- High Throughput Market Sales By Geography (USD MN)
- Molecular Imaging Market Sales By Geography (USD MN)
- OMICS Technology Market Sales By Geography (USD MN)
- Global Market Analysis By Application (USD MN)
- Systemic Toxicity Market Sales By Geography (USD MN)
- Renal Toxicity Market Sales By Geography (USD MN)
- Hepatotoxicity Market Sales By Geography (USD MN)
- Neurotoxicity Market Sales By Geography (USD MN)
- Other Toxicities Market Sales By Geography (USD MN)
- Global Market Analysis By Method (USD MN)
- Cellular Assay Market Sales By Geography (USD MN)
- Biochemical Assay Market Sales By Geography (USD MN)
- In-Silica Market Sales By Geography (USD MN)
- Ex-vivo Market Sales By Geography (USD MN)
- Global Market Sales (USD MN)
- North America Market Sales (USD MN)
- Europe Market Sales (USD MN)
- Asia Pacific Market Sales (USD MN)
- Latin America Market Sales (USD MN)
- Middle East & Africa Market Sales (USD MN)
- Recent Development in Industry
- Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
The global demand for ADME Toxicology Testing Market is presumed to reach the market size of nearly USD 25.79 Billion by 2032 from USD 10.27 Billion in 2023 with a CAGR of 10.77% under the study period 2024-2032.
ADME is an abbreviation in pharmacology that stands for absorption, distribution, metabolism, and elimination of chemicals and drugs to examine the impact in the human body. These four methods of testing define the impact of specific drug or chemical to the human tissue. ADME toxicology testing is an important procedure before an introduction of new drugs in the market. Such toxicology testing influence the drug levels and kinetics of drug exposure to the body tissue and consequently facilitated the performance in a pharmaceutical manufacturing company to lessen their drug discovery time, testing complications, and to minimize the cost of drug development.
MARKET DYNAMICS
The rising demand from different pharmaceutical and biotechnological organizations across the globe because of the decrease in the cost associated with different tests during the drug development process is stimulating market growth. Moreover, less time taking in the commercialization of new drug and decreasing number of drug testing failures are further pushing the market growth. However, high installation and maintenance cost along with the lack of skilled professionals to operate such a system is expected to curb market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ADME Toxicology Testing. The growth and trends of ADME Toxicology Testing industry provide a holistic approach to this study.
MARKET SEGMENTATION
This section of the ADME Toxicology Testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Technology
- Cell Culture
- High Throughput
- Molecular Imaging
- OMICS Technology
By Application
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Other Toxicities
By Method
- Cellular Assay
- Biochemical Assay
- In-Silica
- Ex-vivo
- Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Global ADME Toxicology Testing Market Report market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the ADME Toxicology Testing market include Thermo Fisher Scientific Inc., Promega Corp., Agilent Technologies Inc., Curia Global Inc., Dassault SysteMes, Beckman Coulter Inc., (Danaher), Catalent Inc., Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, GE HealthCare, Miltenyi Biotec, IQVIA Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1. PREFACE
- 1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology
2. EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3. ADME TOXICOLOGY TESTING - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Technology
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Method
- 3.7.4 Market Attractiveness Analysis By Region
4. VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend
5. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY TECHNOLOGY
- 5.1. Overview By Technology
- 5.2. Historical and Forecast Data Analysis By Technology
- 5.3. Cell Culture Historic and Forecast Sales By Regions
- 5.4. High Throughput Historic and Forecast Sales By Regions
- 5.5. Molecular Imaging Historic and Forecast Sales By Regions
- 5.6. OMICS Technology Historic and Forecast Sales By Regions
6. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION
- 6.1. Overview By Application
- 6.2. Historical and Forecast Data Analysis By Application
- 6.3. Systemic Toxicity Historic and Forecast Sales By Regions
- 6.4. Renal Toxicity Historic and Forecast Sales By Regions
- 6.5. Hepatotoxicity Historic and Forecast Sales By Regions
- 6.6. Neurotoxicity Historic and Forecast Sales By Regions
- 6.7. Other Toxicities Historic and Forecast Sales By Regions
7. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY METHOD
- 7.1. Overview By Method
- 7.2. Historical and Forecast Data Analysis By Method
- 7.3. Cellular Assay Historic and Forecast Sales By Regions
- 7.4. Biochemical Assay Historic and Forecast Sales By Regions
- 7.5. In-Silica Historic and Forecast Sales By Regions
- 7.6. Ex-vivo Historic and Forecast Sales By Regions
8. GLOBAL ADME TOXICOLOGY TESTING MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
- 8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
- 8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
- 8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
- 8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE ADME TOXICOLOGY TESTING COMPANIES
- 9.1. ADME Toxicology Testing Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10. COMPANY PROFILES OF ADME TOXICOLOGY TESTING INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Thermo Fisher Scientific Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
- 10.4. Promega Corp.
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
- 10.5. Agilent Technologies Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
- 10.6. Curia Global Inc.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
- 10.7. Dassault SysteMes
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
- 10.8. Beckman Coulter Inc.
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
- 10.9. Danaher
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
- 10.10. Catalent Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
- 10.11. Charles River Laboratories
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
- 10.12. Labcorp Drug Development
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
- 10.13. Eurofins Scientific
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
- 10.14. GE HealthCare
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
- 10.15. Miltenyi Biotec
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
- 10.16. IQVIA Inc
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
